Your browser doesn't support javascript.
loading
Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection.
Carr, Edward J; Wu, Mary Y; Gahir, Joshua; Harvey, Ruth; Townsley, Hermaleigh; Bailey, Chris; Fowler, Ashley S; Dowgier, Giulia; Hobbs, Agnieszka; Herman, Lou; Ragno, Martina; Miah, Murad; Bawumia, Phillip; Smith, Callie; Miranda, Mauro; Mears, Harriet V; Adams, Lorin; Haptipoglu, Emine; O'Reilly, Nicola; Warchal, Scott; Sawyer, Chelsea; Ambrose, Karen; Kelly, Gavin; Beale, Rupert; Papineni, Padmasayee; Corrah, Tumena; Gilson, Richard; Gamblin, Steve; Kassiotis, George; Libri, Vincenzo; Williams, Bryan; Swanton, Charles; Gandhi, Sonia; Lv Bauer, David; Wall, Emma C.
Affiliation
  • Carr EJ; The Francis Crick Institute, London, UK; University College London, London, UK.
  • Wu MY; COVID Surveillance Unit, London, UK; The Francis Crick Institute, London, UK.
  • Gahir J; The Francis Crick Institute, London, UK; National Institute for Health Research University College London Hospitals Biomedical Research Centre and Clinical Research Facility, London, UK.
  • Harvey R; Worldwide Influenza Centre, London, UK.
  • Townsley H; The Francis Crick Institute, London, UK; National Institute for Health Research University College London Hospitals Biomedical Research Centre and Clinical Research Facility, London, UK.
  • Bailey C; The Francis Crick Institute, London, UK; National Institute for Health Research University College London Hospitals Biomedical Research Centre and Clinical Research Facility, London, UK.
  • Fowler AS; The Francis Crick Institute, London, UK.
  • Dowgier G; COVID Surveillance Unit, London, UK.
  • Hobbs A; COVID Surveillance Unit, London, UK.
  • Herman L; COVID Surveillance Unit, London, UK.
  • Ragno M; COVID Surveillance Unit, London, UK.
  • Miah M; The Francis Crick Institute, London, UK.
  • Bawumia P; The Francis Crick Institute, London, UK.
  • Smith C; The Francis Crick Institute, London, UK.
  • Miranda M; The Francis Crick Institute, London, UK.
  • Mears HV; The Francis Crick Institute, London, UK.
  • Adams L; Worldwide Influenza Centre, London, UK.
  • Haptipoglu E; The Francis Crick Institute, London, UK; National Institute for Health Research University College London Hospitals Biomedical Research Centre and Clinical Research Facility, London, UK.
  • O'Reilly N; The Francis Crick Institute, London, UK.
  • Warchal S; The Francis Crick Institute, London, UK.
  • Sawyer C; The Francis Crick Institute, London, UK.
  • Ambrose K; The Francis Crick Institute, London, UK.
  • Kelly G; The Francis Crick Institute, London, UK.
  • Beale R; The Francis Crick Institute, London, UK; University College London, London, UK.
  • Papineni P; London Northwest University Healthcare NHS Trust, London, UK.
  • Corrah T; London Northwest University Healthcare NHS Trust, London, UK.
  • Gilson R; Central and North West London NHS Foundation Trust, London, UK.
  • Gamblin S; The Francis Crick Institute, London, UK.
  • Kassiotis G; The Francis Crick Institute, London, UK; Department of Infectious Disease, St Mary's Hospital, Imperial College London, London, UK.
  • Libri V; University College London, London, UK; National Institute for Health Research University College London Hospitals Biomedical Research Centre and Clinical Research Facility, London, UK.
  • Williams B; University College London, London, UK; National Institute for Health Research University College London Hospitals Biomedical Research Centre and Clinical Research Facility, London, UK.
  • Swanton C; The Francis Crick Institute, London, UK; University College London, London, UK.
  • Gandhi S; The Francis Crick Institute, London, UK; University College London, London, UK.
  • Lv Bauer D; The Francis Crick Institute, London, UK.
  • Wall EC; The Francis Crick Institute, London, UK; University College London, London, UK; National Institute for Health Research University College London Hospitals Biomedical Research Centre and Clinical Research Facility, London, UK. Electronic address: emma.wall@crick.ac.uk.
Lancet Infect Dis ; 23(7): 781-784, 2023 Jul.
Article in En | MEDLINE | ID: mdl-37290472

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines, Combined / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Antibodies, Viral Limits: Adult / Humans Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2023 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines, Combined / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Antibodies, Viral Limits: Adult / Humans Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2023 Type: Article Affiliation country: United kingdom